Projects per year
Personal profile
Education
- Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 1992-1999 M.D., School of Medicine, National Taiwan University
Experience
- 2024.08- Chairperson, Taipei Cancer Center, Taipei Medical University
- 2024.08- Medical Deputy Director, Department of Medical Administration, Taipei Medical University-Shuang Ho
- 2022.02- Associate Professor, Department of Surgery, School of Medicine, Taipei Medical University
- 2021.11-2024.07 Vice Director, Department of Surgery, Taipei Medical University Shuang Ho Hospital
- Director, Division of General Surgery, Department of Surgery, Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare
- 2015.11-2022.01 Assistant Professor, Department of Surgery, School of Medicine, Taipei Medical University
- 2006.07-2011.02 Attending Physician, Far Eastern Memorial Hospital
- 2001.07-2006.06 Resident Physician, National Taiwan University Hospital
Research Interests
- 一般外科
Fingerprint
Dive into the research topics where Hsin-An Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Regulation of M6a Rna Methylation in Pancreatic Ductal Adenocarcinoma and Its Impact on Chemotherapy Resistance
Chen, H.-A. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
探討雷公藤內酯在胰臟癌中增強化療藥物的效果及誘導鐵凋亡作用之機制
Chen, H.-A. (PI)
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
探討雷公藤內酯在胰臟癌中增強化療藥物的效果及誘導鐵凋亡作用之機制
Chen, H.-A. (PI)
1/1/20 → 12/1/20
Project: B - Project of TMU › h - Higher Education Sprout Project
-
The Potential Application of a Natural Compound, Tripolate, for Enhancing the Therapeutic Efficacy of Sorafenib in Hepatic Cancer
Chen, H.-A. (PI)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
探討代謝重整、非編碼核糖核酸與腫瘤抑制因子之相互作用對胰臟癌Gemcitabine抗藥性的影響及其在轉譯醫學上的應用: 鑑定腫瘤分子機制與找尋具潛力之治療標靶 (第二年)-表觀體學對胰腺癌代謝重編程的影響
Chen, H.-A. (PI)
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
-
Author Correction: Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells (Experimental & Molecular Medicine, (2024), 56, 9, (2065-2081), 10.1038/s12276-024-01300-4)
Park, J. M., Su, Y. H., Fan, C. S., Chen, H. H., Qiu, Y. K., Chen, L. L., Chen, H. A., Ramasamy, T. S., Chang, J. S., Huang, S. Y., Chang, W. S. W., Lee, A. Y. L., Huang, T. S., Kuo, C. C. & Chiu, C. F., Mar 2025, In: Experimental and Molecular Medicine. 57, 3, p. 700-701 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma
Wang, W. Y., Hsu, T. W., Su, Y. H., Su, C. M., Wang, T. H., Chiu, C. F., Tsai, K. Y., Huang, C. Y., Chen, H. A. & Liao, P. H., 2025, In: International Journal of Medical Sciences. 22, 16, p. 4353-4364 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells
Park, J. M., Su, Y. H., Fan, C. S., Chen, H. H., Qiu, Y. K., Chen, L. L., Chen, H. A., Ramasamy, T. S., Chang, J. S., Huang, S. Y., Chang, W. S. W., Lee, A. Y. L., Huang, T. S., Kuo, C. C. & Chiu, C. F., Sept 2024, In: Experimental and Molecular Medicine. 56, 9, p. 2065-2081 17 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Nrf2-mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells through ferroptosis escape
Hsu, T. W., Wang, W. Y., Chen, A., Chiu, C. F., Liao, P. H., Chen, H. A., Su, C. M., Shen, S. C., Tsai, K. Y., Wang, T. H. & Su, Y. H., 2024, (Accepted/In press) In: Journal of Cellular Physiology. 239, 12, e31416.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
The Role of Dicer Phosphorylation in Gemcitabine Resistance of Pancreatic Cancer
Chiu, C. F., Lin, H. R., Su, Y. H., Chen, H. A., Hung, S. W. & Huang, S. Y., Nov 2024, In: International journal of molecular sciences. 25, 21, 11797.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)